Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer’s disease: an exploration of underlying mechanisms

Psychopharmacology

Volumn 234, Issue 12, 2017, Pages 1841-1852

  Kiasalari, Zahra ^a   Heydarifard, Rana ^a   Khalili, Mohsen ^a   Afshin Majd, Siamak ^a   Baluchnejadmojarad, Tourandokht ^b   Zahedi, Elham ^a   Sanaierad, Ashkan ^a   Roghani, Mehrdad ^a  

^a SHAHED UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer s disease; Amyloid beta; Ellagic acid; Learning and memory; Neuroinflammation; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CHOLINESTERASE; ELLAGIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT;

ADULT; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; LEARNING DISORDER; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIAL ARM MAZE TEST; RAT; REFERENCE MEMORY; SIGNAL TRANSDUCTION; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY; Y-MAZE TEST; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; RECALL; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; MENTAL RECALL; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 85015712685     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-017-4589-6     Document Type: Article

References (80)

1. Ahshin-Majd S, Zamani S, Kiamari T, Kiasalari Z, Baluchnejadmojarad T, Roghani M (2016) Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: possible involved mechanisms. Peptides 86:102–111. doi:10.1016/j.peptides.2016.10.008
2. Baek B, Lee SH, Kim K, Lim HW, Lim CJ (2016) Ellagic acid plays a protective role against UV-B-induced oxidative stress by up-regulating antioxidant components in human dermal fibroblasts. Korean J Physiol Pharmacol 20:269–277. doi:10.4196/kjpp.2016.20.3.269
3. Bales KR, Du Y, Dodel RC, Yan GM, Hamilton-Byrd E, Paul SM (1998) The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 57:63–72
4. Baluchnejadmojarad T, Roghani M (2012) Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress. Iran J Pharm Res 11:1243–1253
5. Baluchnejadmojarad T, Kiasalari Z, Afshin-Majd S, Ghasemi Z, Roghani M (2017) S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase. Eur J Pharmacol 794:69–76. doi:10.1016/j.ejphar.2016.11.033
6. Bergin DH, Liu P (2010) Agmatine protects against beta-amyloid25-35-induced memory impairments in the rat. Neuroscience 169:794–811. doi:10.1016/j.neuroscience.2010.05.004
7. Bogachouk AP, Storozheva ZI, Solovjeva OA, Sherstnev VV, Zolotarev YA, Azev VN, Rodionov IL, Surina EA, Lipkin VM (2016) Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease. J Psychopharmacol 30:78–92. doi:10.1177/0269881115616393
8. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59:290–294. doi:10.1016/j.neuropharm.2010.04.005
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
10. Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A, Cavalli A (2013) Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease. PLoS One 8:e56870. doi:10.1371/journal.pone.0056870
11. Chen G, Zhang S, Shi J, Ai J, Qi M, Hang C (2009) Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 216:398–406. doi:10.1016/j.expneurol.2008.12.019
12. Chen DL, Zhang P, Lin L, Zhang HM, Deng SD, Wu ZQ, Ou S, Liu SH, Wang JY (2014) Protective effects of bajijiasu in a rat model of Abeta(2)(5)(-)(3)(5)-induced neurotoxicity. J Ethnopharmacol 154:206–217. doi:10.1016/j.jep.2014.04.004
13. Choi YY, Maeda T, Fujii H, Yokozawa T, Kim HY, Cho EJ, Shibamoto T (2014) Oligonol improves memory and cognition under an amyloid beta(25-35)-induced Alzheimer's mouse model. Nutr Res 34:595–603. doi:10.1016/j.nutres.2014.06.008
14. Cioanca O, Hritcu L, Mihasan M, Hancianu M (2013) Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid beta(1-42) rat model of Alzheimer's disease. Physiol Behav 120:193–202. doi:10.1016/j.physbeh.2013.08.006
15. Claiborne A (1985) Catalase activity. In: Greenwald RA (ed). CRC handbook of methods for oxygen radical research. Boca Raton, FL: CRC. 283–284
16. Daulatzai MA (2010) Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease. J Alzheimers Dis 20:355–367. doi:10.3233/jad-2010-1374
17. Ding BJ, Ma WW, He LL, Zhou X, Yuan LH, Yu HL, Feng JF, Xiao R (2011) Soybean isoflavone alleviates beta-amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-kappaB activity in rats. Int J Dev Neurosci 29:537–542. doi:10.1016/j.ijdevneu.2011.04.002
18. Dolatshahi M, Farbood Y, Sarkaki A, Mansouri SM, Khodadadi A (2015) Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson's disease. Iran J Basic Med Sci 18:38–46
19. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77
20. Farbood Y, Sarkaki A, Dianat M, Khodadadi A, Haddad MK, Mashhadizadeh S (2015) Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury. Life Sci 124:120–127. doi:10.1016/j.lfs.2015.01.013
21. Fedotova J, Soultanov V, Nikitina T, Roschin V, Ordyan N, Hritcu L (2016) Cognitive-enhancing activities of the polyprenol preparation Ropren(R) in gonadectomized beta-amyloid (25-35) rat model of Alzheimer's disease. Physiol Behav 157:55–62. doi:10.1016/j.physbeh.2016.01.035
22. Ferreres F, Grosso C, Gil-Izquierdo A, Valentao P, Andrade PB (2013) Ellagic acid and derivatives from Cochlospermum angolensis Welw. extracts: HPLC-DAD-ESI/MS(n) profiling, quantification and in vitro anti-depressant, anti-cholinesterase and anti-oxidant activities. Phytochem Anal 24:534–540. doi:10.1002/pca.2429
23. Galasko D, Montine TJ (2010) Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med 4:27–36. doi:10.2217/bmm.09.89
24. Ghofrani S, Joghataei MT, Mohseni S, Baluchnejadmojarad T, Bagheri M, Khamse S, Roghani M (2015) Naringenin improves learning and memory in an Alzheimer's disease rat model: insights into the underlying mechanisms. Eur J Pharmacol 764:195–201. doi:10.1016/j.ejphar.2015.07.001
25. Golde TE (2016) Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies. J Neurochem 139:224–236. doi:10.1111/jnc.13583
26. Gomes GM, Dalmolin GD, Bar J, Karpova A, Mello CF, Kreutz MR, Rubin MA (2014) Inhibition of the polyamine system counteracts beta-amyloid peptide-induced memory impairment in mice: involvement of extrasynaptic NMDA receptors. PLoS One 9:e99184. doi:10.1371/journal.pone.0099184
27. Guo LL, Guan ZZ, Huang Y, Wang YL, Shi JS (2013) The neurotoxicity of beta-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. Exp Toxicol Pathol 65:579–584. doi:10.1016/j.etp.2012.05.003
28. Hamad A-WR, Al-Momani WM, Janakat S, Oran SA (2009) Bioavailability of ellagic acid after single dose administration using HPLC. Pak J Nutr 8:1661–1664
29. Hassoun EA, Vodhanel J, Abushaban A (2004) The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol 18:196–203. doi:10.1002/jbt.20030
30. Hritcu L, Cioanca O, Hancianu M (2012) Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 19:529–534. doi:10.1016/j.phymed.2012.02.002
31. Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Kuete V, Mihasan M (2014) Methanolic extract of Piper nigrum fruits improves memory impairment by decreasing brain oxidative stress in amyloid beta(1-42) rat model of Alzheimer's disease. Cell Mol Neurobiol 34:437–449. doi:10.1007/s10571-014-0028-y
32. Hseu YC, Chou CW, Senthil Kumar KJ, Fu KT, Wang HM, Hsu LS, Kuo YH, Wu CR, Chen SC, Yang HL (2012) Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem Toxicol 50:1245–1255. doi:10.1016/j.fct.2012.02.020
33. Hwang JM, Cho JS, Kim TH, Lee YI (2010) Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species. Biomed Pharmacother 64:264–270. doi:10.1016/j.biopha.2009.06.013
34. Isomae K, Morimoto S, Hasegawa H, Morita K, Kamei J (2003) Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats. Eur J Pharmacol 465:97–103
35. Jiang LF, Liao HL, Huang HM, Zhou LX, Li L, Cheng SX, Du CZ (2013) Potential prevention and treatment of maifanite for Alzheimer's disease based on behavior test, oxidative stress assay, and trace element analysis in hippocampus of Abeta((2)(5)(-)(3)(5))-induced AD rats. Biol Trace Elem Res 152:50–56. doi:10.1007/s12011-012-9590-7
36. Jimenez-Aliaga K, Bermejo-Bescos P, Benedi J, Martin-Aragon S (2011) Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci 89:939–945. doi:10.1016/j.lfs.2011.09.023
37. Johnston H, Boutin H, Allan SM (2011) Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans 39:886–890. doi:10.1042/bst0390886
38. Kabiraj P, Marin JE, Varela-Ramirez A, Zubia E, Narayan M (2014) Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers. ACS Chem Neurosci 5:1209–1220. doi:10.1021/cn500214k
39. Kiasalari Z, Khalili M, Shafiee S, Roghani M (2016) The effect of vitamin E on learning and memory deficits in intrahippocampal kainate-induced temporal lobe epilepsy in rats. Indian J Pharmacol 48:11–14. doi:10.4103/0253-7613.174394
40. Kim M, Kim SO, Lee M, Lee JH, Jung WS, Moon SK, Kim YS, Cho KH, Ko CN, Lee EH (2014) Tetramethylpyrazine, a natural alkaloid, attenuates pro-inflammatory mediators induced by amyloid beta and interferon-gamma in rat brain microglia. Eur J Pharmacol 740:504–511. doi:10.1016/j.ejphar.2014.06.037
41. Lau L-F, Brodney MA (2008) Therapeutic approaches for the treatment of Alzheimer's disease: an overview. In: Lau L-F, Brodney MA (eds) Alzheimer's disease. Springer Berlin, pp 1–24
42. Lee JH, Won JH, Choi JM, Cha HH, Jang YJ, Park S, Kim HG, Kim HC, Kim DK (2014) Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor kappaB signaling pathways. J Agric Food Chem 62:10110–10117. doi:10.1021/jf503188c
43. Li W, Kong AN (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 48:91–104. doi:10.1002/mc.20465
44. Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Yu AC (2011) Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res 8:67–80
45. Limon ID, Mendieta L, Diaz A, Chamorro G, Espinosa B, Zenteno E, Guevara J (2009) Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35)). Neurosci Lett 453:98–103. doi:10.1016/j.neulet.2009.02.011
46. Liu RT, Zou LB, Fu JY, Lu QJ (2010) Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid beta-peptide (25-35) in rats. Behav Brain Res 210:24–31. doi:10.1016/j.bbr.2010.01.041
47. Liu H, Deng Y, Gao J, Liu Y, Li W, Shi J, Gong Q (2015) Sodium hydrosulfide attenuates beta-amyloid-induced cognitive deficits and neuroinflammation via modulation of MAPK/NF-kappaB pathway in rats. Curr Alzheimer Res 12:673–683
48. Ma Q, Ruan YY, Xu H, Shi XM, Wang ZX, Hu YL (2015a) Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid beta-induced impairment of learning and memory in rats. Biomed Pharmacother 76:153–164. doi:10.1016/j.biopha.2015.10.004
49. Ma W, Ding B, Yu H, Yuan L, Xi Y, Xiao R (2015b) Genistein alleviates beta-amyloid-induced inflammatory damage through regulating Toll-like receptor 4/nuclear factor kappaB. J Med Food 18:273–279. doi:10.1089/jmf.2014.3150
50. Mansouri MT, Farbood Y, Naghizadeh B, Shabani S, Mirshekar MA, Sarkaki A (2016) Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments. Pharm Biol 54:1947–1953. doi:10.3109/13880209.2015.1137601
51. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430:631–639. doi:10.1038/nature02621
52. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376–389
53. Mufson EJ, Presley LN, Kordower JH (1991) Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons. Brain Res 539:19–30
54. Nasri S, Roghani M, Baluchnejadmojarad T, Balvardi M, Rabani T (2012) Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats. Phytother Res 26:1205–1210. doi:10.1002/ptr.3702
55. Nirwane A, Sridhar V, Majumdar A (2016) Neurobehavioural changes and brain oxidative stress induced by acute exposure to GSM900 mobile phone radiations in zebrafish (Danio rerio). Toxicol Res 32:123–132. doi:10.5487/tr.2016.32.2.123
56. Olton DS, Samuelson RJ (1976) Remembrance of places passed: spatial memory in rats. J Exp Psychol Anim Behav Process 2:97–116
57. O'Neal-Moffitt G, Delic V, Bradshaw PC, Olcese J (2015) Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AbetaPP(swe)/PS1 mice. Mol Neurodegener 10:27. doi:10.1186/s13024-015-0027-6
58. Patricio-Martinez A, Mendieta L, Martinez I, Aguilera J, Limon ID (2016) The recombinant C-terminal fragment of tetanus toxin protects against cholinotoxicity by intraseptal injection of beta-amyloid peptide (25-35) in rats. Neuroscience 315:18–30. doi:10.1016/j.neuroscience.2015.11.066
59. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
60. Pimplikar SW (2014) Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target. J Clin Immunol 34(Suppl 1):S64–S69. doi:10.1007/s10875-014-0032-5
61. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H (2002) Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 50:2200–2206
62. Rasoolijazi H, Joghataie MT, Roghani M, Nobakht M (2007) The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iran Biomed J 11:237–243
63. Roghani M, Joghataie MT, Jalili MR, Baluchnejadmojarad T (2006) Time course of changes in passive avoidance and y-maze performance in male diabetic rats. Iran Biomed J 10:99–104
64. Sánchez-González C, Ciudad C, Noé V, Izquierdo-Pulido M (2015) Health benefits of walnut polyphenols: an exploration beyond their lipid profile. Crit Rev Food Sci Nutr:00–00
65. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192–205
66. Sohanaki H, Baluchnejadmojarad T, Nikbakht F, Roghani M (2016a) Pelargonidin improves memory deficit in amyloid beta25-35 rat model of Alzheimer's disease by inhibition of glial activation, cholinesterase, and oxidative stress. Biomed Pharmacother 83:85–91. doi:10.1016/j.biopha.2016.06.021
67. Sohanaki H, Baluchnejadmojarad T, Nikbakht F, Roghani M (2016b) Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer's disease via estrogen receptor independent pathways. Acta Med Iran 54:245–250
68. Stuart SA, Robertson JD, Marrion NV, Robinson ES (2013) Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory. PLoS One 8:e75467. doi:10.1371/journal.pone.0075467
69. Swomley AM, Butterfield DA (2015) Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics. Arch Toxicol 89:1669–1680. doi:10.1007/s00204-015-1556-z
70. Teel RW (1987) Distribution and metabolism of ellagic acid in the mouse following intraperitoneal administration. Cancer Lett 34:165–171
71. Uzar E, Alp H, Cevik MU, Firat U, Evliyaoglu O, Tufek A, Altun Y (2012) Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci 33:567–574. doi:10.1007/s10072-011-0775-1
72. Vomhof-Dekrey EE, Picklo MJ Sr (2012) The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J Nutr Biochem 23:1201–1206. doi:10.1016/j.jnutbio.2012.03.005
73. Wang H, Yu Y, Chen W, Cui Y, Luo T, Ma J, Jiang XC, Qin S (2014) PLTP deficiency impairs learning and memory capabilities partially due to alteration of amyloid-beta metabolism in old mice. J Alzheimers Dis 39:79–88. doi:10.3233/jad-130812
74. Yan L, Yin P, Ma C, Liu Y (2014) Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Molecules 19:18923–18935. doi:10.3390/molecules191118923
75. Yang Y, Jiang S, Yan J, Li Y, Xin Z, Lin Y, Qu Y (2015) An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev 26:47–57. doi:10.1016/j.cytogfr.2014.09.002
76. Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181–213. doi:10.1016/j.bbi.2010.10.015
77. Zarezadeh M, Baluchnejadmojarad T, Kiasalari Z, Afshin-Majd S, Roghani M (2017) Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: possible involved mechanisms. Eur J Pharmacol 795:13–21. doi:10.1016/j.ejphar.2016.11.051
78. Zhang Z, Hou L, Li X, Ju C, Zhang J, Li X, Wang X, Liu C, Lv Y, Wang Y (2016) Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and alpha-synuclein aggregation in 6-OHDA induced parkinsons disease cell model. Brain Res 1633:87–95. doi:10.1016/j.brainres.2015.12.035
79. Zhi WH, Zeng YY, Lu ZH, Qu WJ, Chen WX, Chen L, Chen L (2014) Simvastatin exerts antiamnesic effect in Abeta25-35-injected mice. CNS Neurosci Ther 20:218–226. doi:10.1111/cns.12190
80. Zhou L, Lu Z, Li L, Chen L, Qi J, Chen L (2014) Pro-neurogenesis and anti-dementia properties of tetradecyl 2,3-dihydroxybenzoate through TrkA receptor-mediated signalling pathways. Int J Neuropsychopharmacol 17:1847–1861. doi:10.1017/s1461145714000558